Gianluca Vullo

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Neoadjuvant Chemotherapy

Radiation Induced

Prognostic Factors

Top Venues

Journal of personalized medicine

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Giuseppe Facondo, Gianluca Vullo, Vitaliana De Sanctis, Margherita Rotondi, Riccardo Carlo Sigillo, Maurizio Valeriani, Mattia Falchetto Osti
Clinical Outcomes of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Patients with Lymph Node Metastases from Gynecological Cancers. Journal of personalized medicine 13 (2) (2023)
Giuseppe Facondo, Gianluca Vullo, Vitaliana De Sanctis, Margherita Rotondi, Riccardo Carlo Sigillo, Maurizio Valeriani, Mattia Falchetto Osti
Clinical Outcomes of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Patients with Lymph Node Metastases from Gynecological Cancers. Journal of personalized medicine 13 (2) (2023)
Giuseppe Facondo, Gianluca Vullo, Vitaliana De Sanctis, Margherita Rotondi, Riccardo Carlo Sigillo, Maurizio Valeriani, Mattia Falchetto Osti
Clinical Outcomes of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Patients with Lymph Node Metastases from Gynecological Cancers. Journal of personalized medicine 13 (2) (2023)
Giuseppe Facondo, Mattia Serio, Gianluca Vullo, Maria Paola Bianchi, Sabrina Pelliccia, Alice Di Rocco, Tiziana Lanzolla, Maurizio Valeriani, Arianna Di Napoli, Agostino Tafuri, Maurizio Martelli, Mattia Falchetto Osti, Vitaliana De Sanctis
Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study. Journal of clinical medicine 12 (11) (2023)
Maurizio Valeriani, Mario Di Staso, Giuseppe Facondo, Gianluca Vullo, Vitaliana De Sanctis, Giovanni Luca Gravina, Milena di Genesio Pagliuca, Mattia Falchetto Osti, Pierluigi Bonfili
Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results. Journal of clinical medicine 11 (16) (2022)